Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nanobiotix S.A. ADR (NQ: NBTX ) 4.160 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nanobiotix S.A. ADR < Previous 1 2 3 4 5 6 7 8 9 Next > NANOBIOTIX Announces the Appointment of Bart Van Rhijn as Chief Financial Officer and Member of the Executive Board to Support Global Expansion June 01, 2021 From NANOBIOTIX Via Business Wire NANOBIOTIX to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference May 26, 2021 From NANOBIOTIX Via Business Wire Nanobiotix Announces the Appointment of Dr. Gary Phillips as Chairman of the Nanobiotix Supervisory Board May 25, 2021 From Nanobiotix Via Business Wire CORRECTING and REPLACING Nanobiotix Announces Updated Results From Priority Pathways in Head and Neck Cancer and Immunotherapy for Potential First-in-class Radioenhancer NBTXR3 at 2021 Annual Meeting of the American Society for Clinical Oncology May 21, 2021 From Nanobiotix Via Business Wire Nanobiotix Announces Updated Results From Priority Pathways in Head and Neck Cancer and Immunotherapy for Potential First-in-class Radioenhancer NBTXR3 at 2021 Annual Meeting of the American Society for Clinical Oncology May 19, 2021 From Nanobiotix Via Business Wire Nanobiotix to Present at the UBS Global Healthcare Virtual Conference May 12, 2021 From Nanobiotix Via Business Wire Nanobiotix, LianBio Ink NBTXR3 Development Pact In Asia For Solid Tumor Settings May 12, 2021 Nanobiotix (NASDAQ: NBTX) has announced a partnership with LianBio to develop and commercialize Nanobiotix's lead product candidate NBTXR3, in... Via Benzinga NANOBIOTIX Partners With LianBio to Develop and Commercialize Potential First-in-Class Radioenhancer NBTXR3 Across Tumor Types and Therapeutic Combinations in China and Other Asian Markets May 11, 2021 From NANOBIOTIX Via Business Wire NANOBIOTIX Announces First Quarter Operational and Financial Updates April 29, 2021 From NANOBIOTIX Via Business Wire NANOBIOTIX to Present Four Posters Including Updates From Priority Head and Neck Cancer and Immunotherapy Development Pathways at the 2021 Annual Meeting of the American Society for Clinical Oncology April 28, 2021 From NANOBIOTIX Via Business Wire 12 Health Care Stocks Moving In Friday's Intraday Session April 16, 2021 Gainers BioCryst Pharmaceuticals (NASDAQ:BCRX) shares rose 11.13% to $11.32 during Friday's regular session. As of 08:06 EST, this security is trading at a volume of 8... Via Benzinga Nanobiotix Combined Shareholders Meeting to Be Held April 28, 2021 April 12, 2021 From Nanobiotix Via Business Wire The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx April 24, 2021 Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... Via Benzinga Exposures Product Safety NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F April 07, 2021 From NANOBIOTIX Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
